|
Originally published In Press as doi:10.1074/jbc.M107828200 on October 1, 2001
J. Biol. Chem., Vol. 276, Issue 49, 46544-46552, December 7, 2001
Polycystin-1 Interacts with Intermediate
Filaments*
G. Mark
Xu ,
Tabo
Sikaneta§,
Brandon M.
Sullivan,
Qunhao
Zhang,
Michele
Andreucci,
Thilo
Stehle,
Iain
Drummond, and
M. Amin
Arnaout¶
From the Renal Unit, Massachusetts General Hospital and Harvard
Medical School, Charlestown, Massachusetts 02129
Received for publication, August 14, 2001, and in revised form, September 25, 2001
 |
ABSTRACT |
Polycystin-1, the protein defective in a majority
of patients with autosomal dominant polycystic kidney disease, is a
ubiquitously expressed multi-span transmembrane protein of unknown
function. Subcellular localization studies found this protein to be a
component of various cell junctional complexes and to be associated
with the cytoskeleton, but the specificity and nature of such
associations are not known. To identify proteins that interact with the
polycystin-1 C-tail (P1CT), this segment was used as bait in a yeast
two-hybrid screening of a kidney epithelial cell library. The
intermediate filament (IF) protein vimentin was identified as a strong
polycystin-1-interacting partner. Cytokeratins K8 and K18 and desmin
were also found to interact with P1CT. These interactions were mediated
by coiled-coil motifs in polycystin-1 and IF proteins. Vimentin,
cytokeratins K8 and K18, and desmin also bound directly to P1CT in GST
pull-down and in in vitro filament assembly assays. Two
observations confirmed these interactions in vivo: (i) a
cell membrane-anchored form of recombinant P1CT decorated the IF
network and was found to associate with the cytoskeleton in
detergent-solubilized cells and (ii) endogenous polycystin-1
distributed with IF at desmosomal junctions. Polycystin-1 may utilize
this association for structural, storage, or signaling functions.
 |
INTRODUCTION |
Autosomal dominant polycystic kidney disease
(ADPKD)1 is one of the most
common genetic diseases in humans, affecting ~1 in 400 individuals
and accounting for 8-10% of end stage renal disease (1). ADPKD is
characterized by the formation and progressive expansion of cysts in
ductal organs including both kidneys as well as by cardiovascular
abnormalities. About 85% of ADPKD cases are caused by defects in
polycystin-1 (2, 3), a broadly expressed and developmentally regulated
multi-span transmembrane protein with a large extracellular region rich
in protein-protein and protein-carbohydrate interaction modules.
Although this composition is suggestive of a role in cell-cell and/or
cell-matrix adhesion, the precise function(s) mediated by polycystin-1
remains unknown.
Genetic, immunochemical, and biochemical studies have suggested that
polycystin-1 is involved in maintaining the structural integrity of
cell-cell junctions in vascular and epithelial structures. In mouse
models of ADPKD, mouse embryos lacking a functional polycystin-1 are
uniformly edematous (4, 5) and die in utero of hemorrhages preceded by vascular leaks (4). Consistent with these data, polycystin-1 has been shown to distribute at apicolateral cell junctions in both epithelial and endothelial cells (6-9).
Immunolocalization and/or cell fractionation studies found polycystin-1
at tight (10), adherens (7), and desmosomal (9) junctions, at focal contacts (11), and in the cytoplasm. A fraction has also been found in
the Triton X-100-insoluble cell fraction, reflecting a strong
association with cytoskeleton (12). Recently polycystin-1 was shown to
be transported through a tuberin-dependent pathway to the
lateral domain of cell membranes (13). The nature of the interactions
utilized by polycystin-1 to localize at cell junctions associate with
cytoskeleton or traffic to the cell surface is currently unknown. In
this paper, we have identified a direct and specific interaction of
polycystin-1 with the intermediate filament network. This interaction
is mediated by the cytoplasmic tail of polycystin-1 binding directly to
the IF proteins vimentin, cytokeratins 8 and 18, and desmin.
Interaction was shown initially in a yeast two-hybrid screen of an
epithelial cell library and confirmed both in vitro using
GST pull-down and co-sedimentation assays and in whole cells using
immunofluorescence analysis of both a membrane-anchored polycystin-1
cytoplasmic tail and the endogenous native protein. The functional
significance of this association is discussed.
 |
MATERIALS AND METHODS |
DNA and Plasmid Constructs--
The cDNAs and bacterial
expression vectors for vimentin and desmin were kind gifts from the
following sources: human vimentin cDNA, Dr. Elaine Fuchs
(University of Chicago, Chicago, IL); pET11d-vimentin, Dr. Wallace Ip
(University of Cincinnati College of Medicine, Cincinnati, OH) (14);
and pET3a-desmin, Drs. Masakiv Inagaki and Hiroyasu Inada (Aichi Cancer
Center Research Institute, Nagoya, Japan) (15). The cDNAs for
cytokeratin K8 and K18 were amplified by reverse transcription-PCR from
the human colon carcinoma HT29 cell line. The bacterial expression
vectors for K8 and K18 were constructed by introducing NcoI
and BamHI sites into the 5' and 3' ends of the cDNA by
PCR and subsequently subcloning the cDNA into pET11d (Novagen). For
mammalian expression constructs, cDNAs for vimentin, desmin, K8,
and K18 were PCR-amplified with the introduction of an EcoRI
site at the 5' end and a BglII site at the 3' end. The
digested PCR fragments were then subcloned into the expression vector
pCMV-5FLAG, which tags the FLAG epitope at the N terminus. Murine
polycystin-1 and -2 cDNAs were amplified by reverse
transcription-PCR. Murine cDNAs for the coiled-coil-containing proteins CD2AP (16), occludin (17), axin (18), conductin (19), and
kinesin (20) were also amplified by reverse transcription-PCR. To
construct plasmids for yeast two-hybrid analyses, DNA fragments were
amplified by PCR with the introduction of an in-frame EcoRI site at the 5' end. The PCR products were digested by EcoRI
followed by phosphorylation of the 3' blunt ends. The resulting
fragments were then subcloned into the pLexA or pB42AD vectors
(CLONTECH) between EcoRI and
XhoI (blunted) sites. The fusion construct sIg7P1CT was made
by fusing murine P1CT from amino acids 4098-4293 to the end of CD7
transmembrane span section in the vector sIg7poly (kindly provided by
Dr. Brain Seed, Massachusetts General Hospital, Boston, MA). pCD16.7
PKD 115-226 was a kind gift from Dr. Gerd Walz (Beth Israel Hospital,
Boston, MA) (21). GST-P1CC was constructed by subcloning the
cDNA encoding amino acids 4173-4246 into pGEX-2T (Amersham
Pharmacia Biotech) between the EcoRI and SmaI
sites. All PCR reactions were performed using Vent DNA polymerase (New England Biolabs). The oligonucleotide sequences for plasmid
construction are available upon request.
Yeast Two-hybrid Screen and Analysis--
mRNA from the
collecting duct-derived Madin-Darby canine kidney (MDCK) cells was
isolated using Dynabeads Oligo(dT)25 (Dynal). A yeast
two-hybrid cDNA library in pB42AD was constructed from the mRNA
using the SUPERSCRIPT Choice System for cDNA Synthesis (Life
Technologies, Inc.). The library contains 1.9 × 106
independent clones. Murine P1CT from amino acids 4098-4293 was subcloned into pLexA (pLexA-P1CT) and used as bait to screen the library. This fragment is important for the function of polycystin-1, because mutations within P1CT have been shown to cause ADPKD (22, 23).
Initial candidates were identified by examining leucine auxotrophy and
by galactose-inducible -galactosidase activity. False positives were
eliminated by yeast mating assays according to the
CLONTECH manual (PT3040-1). To test interaction, a
combination of a pLexA bait construct and a pB42AD prey construct were
co-transformed into yeast strain EGY48 (p8op-lacZ). Transformants were
grown on synthetic medium containing 2% galactose plus 1% raffinose but lacking uracil (Ura), histidine (His), and tryptophan (Trp). The
colonies were then either replicated onto a plate lacking leucine (Leu)
to assess growth, or printed onto a filter paper for -galactosidase
analysis using X-gal as a substrate. To measure galactose-inducible
-galactosidase activity, a liquid assay was used; individual yeast
colonies co-transformed with both bait and prey constructs were grown
overnight in the synthetic medium lacking Ura, His, and Trp. The
culture was then diluted 5-fold in fresh medium containing 2%
galactose plus 1% raffinose and allowed to grow for another 5 h.
After this induction period, the cell mass was measured at
A600. The -galactosidase activity was
measured using o-nitrophenyl
-D-galactopyrannoside as a substrate according to the
CLONTECH manual and normalized to the cell mass (as
A420/A600) for comparison.
GST Pull-down Assays--
The bacterial strain Bl21(DE3) was
used for expression of GST or GST-P1CC. Each bacterial culture was
induced by isopropyl-1-thio- -D-galactopyranoside at 0.1 mM and allowed to express protein overnight at room
temperature. The bacterial pellet was lysed by sonication in 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1.5% sarkosyl, plus protease
inhibitors. The supernatant, after centrifugation at 15,000 rpm for 30 min, was incubated with glutathione beads (Amersham Pharmacia Biotech).
The beads were washed and then preabsorbed with 10 mM
Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA, and
6% BSA for 2 h. 10 µl of beads was loaded onto each column. The
column was washed once with 200 µl of lysis buffer (20 mM
Tris-HCl, pH 7.5, 1% Triton X-100, 0.1% SDS, and 5 mM
EDTA) and then loaded with 100 µl of cell lysates containing
FLAG-tagged IF proteins. The beads were washed three times with 200 µl of lysis buffer, and the bound proteins were analyzed by Western
blotting using the anti-FALG antibody M2 (Sigma). For expression of
FLAG-tagged IF proteins, HEK 293 cells in a 35-mm well were transfected
with expression vectors for vimentin, desmin, or cytokeratin K8 plus K18. The cells were lysed 2 days later in 1 ml of lysis buffer, and the
supernatant was used for GST pull-down experiments.
Biotinylation--
The GST-P1CC fusion protein was expressed and
isolated on glutathione beads as described above. The 8-kDa P1CC
fragment was released from the beads by thrombin (Amersham Pharmacia
Biotech) digestion and purified on a Q column (Amersham Pharmacia
Biotech). The protein fractions were dialyzed into 50 mM
HEPES, pH 8.0. N-Hydroxylsuccinimide biotin (Pierce) was
added to the P1CC at a biotin/P1CC molar ratio of 1.5. The reaction was
allowed for 4 h at room temperature and stopped by 2 mM NH4Cl. Uncoupled biotin was removed by
filtration in a spin unit (molecular weight cut-off, 5,000; Millipore),
with the simultaneous change of the buffer to 10 mM
Tris-HCl, pH 8.3, 10 mM -mercaptoethanol, 1 mM EDTA, and 0.1 mM EGTA.
Recombinant IF Protein Preparation and in Vitro Filament
Assembly--
The bacterial strain BL21(DE3) was used for recombinant
IF protein expression. Protein expression was induced by
isopropyl-1-thio- -D-galactopyranoside at 1 mM when the bacterial culture has grown to an optical
density of about 0.6. Four h later, bacteria were pelleted. Proteins
were isolated from inclusion bodies as described (24), except
that sonication instead of DNase I was used to break bacterial genomic DNA. The proteins were initially dissolved in 10 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 5 mM
dithiothreitol, and 8 M urea and then dialyzed into the
same buffer containing 6 M urea. Protein purification was
carried out on a DEAE column (Tosohaas, Montgomeryville, PA). For
cytokeratin K8 and K18, equimolar amounts of K8 and K18 DEAE fractions
were combined, dialyzed into the buffer containing 8 M
urea, and then dialyzed back to the buffer containing 6 M
urea. The mixture was loaded onto a DEAE column for another run of
chromatography to isolate the K8/K18 heterodimers (25). To carry out
the co-sedimentation analysis, vimentin, desmin, and K8/K18 were
stepwise dialyzed from 8, 4, 2, to 1 M urea and then into a
high pH/low salt buffer consisting of 10 mM Tris-HCl, pH
8.3, 10 mM -mercaptoethanol, 1 mM EDTA, and
0.1 mM EGTA (26). The resulting solution was centrifuged at
100,000 × g for 15 min to remove any aggregates. 100 µg of IF proteins were then incubated with 0.15 or 0.015 µg of
biotinylated P1CC (P1CC/IF molar ratios of 0.01 and 0.001, respectively) in a total volume of 450 µl for 1 h at room
temperature. Filament assembly was initiated by adding 50 µl of 0.4 M Tris-HCl, pH 7.0 (K8/K18) or 0.4 M Tris-HCl,
pH 7.0, 0.5 M NaCl, and 10 mM MgCl2
(desmin or vimentin) to the assembly reactions. For controls, 7.5 µg
of biotinylated P1CC was incubated alone or with 100 µg of BSA and
then adjusted to the buffer as for vimentin and desmin. The assembly
reactions were allowed for 2 h at room temperature. Filaments were
pelleted by centrifugation at 30,000 × g for 2 h.
The pellets were dissolved in 200 µl of 8 M urea in 10 mM Tris-HCl, pH 8.0. Five µg of pellet protein and 10 µl of a control sample were analyzed by SDS-PAGE followed by Western
blotting using horseradish peroxidase-coupled streptavidin (Pierce) as
a probe.
Association with Cytoskeleton--
HEK 293 cells were grown in
Dulbecco's modified Eagle's medium supplemented with 10% fetal
bovine serum (FBS). 4 × 105 cells were plated in each
well of a six-well plate 1 day before transfection. 2 µg of plasmid
sIg7P1CT or its deletion construct and 9 µl of LipofectAMINE (Life
Technologies, Inc.) were used for transfection of each well. The cells
were lysed 2 days later in cytoskeleton stabilizing buffer containing
10 mM Pipes, pH 6.8, 100 mM NaCl, 3 mM MgCl2, 0.5% Triton X-100, 300 mM sucrose, and a protease inhibitor mixture (Roche
Molecular Biochemicals) (27). The pellet was dissolved in an equal
volume (200 µl/well) of Tris-HCl, pH 8.0, 6 M urea, 1 mM EDTA. 10 µl of lysate or pellet samples was analyzed
by SDS-PAGE followed by Western blotting using the anti-FLAG antibody
as a probe.
Immunofluorescence--
To examine the subcellular distribution
of the P1CT fusion construct, LLC-PK1 cells were transfected with
plasmid pCD16.7PKD115-226 or its control pCD16.7. Twenty-four h after
transfection, the cells were fixed in 4% paraformaldehyde plus 5%
sucrose in phosphate-buffered saline followed by permeabilization in
1% Triton X-100 in phosphate-buffered saline. The cells were then
incubated for 1 h with antibodies against CD16 (3G8, Pharmingen;
1:100), followed by a 1-h incubation with a fluorescein
isothiocyanate-conjugated anti-mouse secondary antibody (Jackson
Immunoresearch). For some cells, nocodazole (Sigma) was used at a final
concentration of 5 µg/ml for 1 h before fixation. For
localization of endogenous polycystin-1, clone II MDCK cells were grown
on coverslips in minimum essential medium with 10% FBS. The
cells were fixed on ice for 40 min in a solution of 10% acetic acid
and 50% ethanol, followed by incubation for 1 h at room
temperature with a blocking solution containing 3% BSA, 2% FBS, and
0.01% Nonidet P-40. The cells were then incubated with 1:50 dilution
of a rabbit anti-polycystin-1 LRR antibody (kindly provided by O. Ibraghimov-Beskrovnaya, Genzyme) (6) and mouse anti-desmoplakin I and
II antibody (Research Diagnostic, 1:10) in blocking solution for 1 h at room temperature, followed by incubation for 1 h with
Cy3-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Labs,
1:1000) and Cy5-conjugated goat anti-mouse IgG Fab fragments (Jackson
Immunoresearch Labs, 1:1000). After extensive washing, the cells were
incubated with an fluorescein isothiocyanate-conjugated mouse anti-pan
cytokeratins antibody (C-11, Sigma, 1:50) for 1 h and washed. The
coverslips were mounted and examined by confocal microscopy.
Quantification of Polycystin-1 Association with Keratin--
To
quantitate the association of polycystin-1 with keratin filaments,
junctions showing clear individual filaments threading through the
desmosomes were identified in micrographs. The number of filaments
linked to polycystin-1 at desmosomes double-labeled with cytokeratin
and desmoplakin was then counted.
Calcium Switch Experiments--
For these experiments, MDCK
cells grown on coverslips were first depleted of calcium by washing
with Dulbecco's modified Eagle's medium with 10% FBS lacking
calcium chloride (catalog number 21068; Life Technologies,
Inc.) followed by an overnight incubation in the same medium.
Calcium-containing normal Dulbecco's modified Eagle's medium with
10% FBS was then replenished. The cells were removed at different time
points and processed for immunostaining.
 |
RESULTS |
Yeast Two-hybrid Screening of a cDNA Library for
P1CT-interacting Proteins--
To identify proteins that interact
directly with polycystin-1, we carried out a yeast two-hybrid screen of
an epithelial cell library as described (28) using P1CT (29) (Fig.
1A) as bait. Of 4.2 × 106 yeast transformants, only 12 clones encoding six
different proteins showed specific interaction with P1CT. These were
identified by examining leucine auxotrophy and galactose-induced
-galactosidase activity and were confirmed by yeast mating assays.
One of these interactants encoded the C-terminal 126 amino acids of
vimentin (30). No -galactosidase activity was detected above the
negative control when the vimentin clone was co-transformed with an
empty vector or the cytoplasmic tail of polycystin-2 (P2CT) (Fig.
1B), indicating that the interaction was specific. To
evaluate the relative strength of interaction, we normalized the
-galactosidase activity to cell mass
(A420/A600) and compared
it with that of p53-large T-antigen interaction (used as a positive
control). The strength of P1CT-vimentin interaction was ~60% of that
between p53 and the large T-antigen. Of the six proteins identified in the screen, vimentin was the strongest interactor and was further characterized. One of the remaining five proteins (represented in three
of the twelve clones) encoded 14-3-3 (31). The remaining four proteins
are distinct from the known P1CT interactants such as polycystin-2
(32), RGS7 (regulator of G-protein
signaling 7) (33), and PBP-1
(polycystin-1-binding
protein-1) (34). Polycystin-2 is a multi-span
transmembrane channel protein, and it is typically difficult to
identify a transmembrane protein in a yeast two-hybrid screen. RGS7 and
PBP-1 were identified from a B cell and a brain libraries,
respectively. The potential relevance of the four clones in the
function of polycystin-1 is being evaluated.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
Vimentin-P1CT interaction
identified by yeast two-hybrid screening. A, primary
sequence and features of murine P1CT. Three regions (conserved between
human and mouse) shown or predicted to interact with other proteins are
in bold type. The first is a G-protein activation sequence
(57). The second, the coiled-coil domain consisting of five 7-amino
acid repeats, is a binding site for polycystin-2, PBP-1, and RGS7. The
third region forms a potential SH3-binding site (57).
Underlined are a potential c-Src phosphorylation site (61)
(Y4227) and a cAMP-dependent protein kinase site (60).
B, filter assay of yeast two-hybrid interactions and
quantitation of interaction strength by liquid assay. The original data
were expressed as
A420/A600 and normalized
to the mean of p53-T-antigen interaction, which was set at 100. The
histograms represent the means ± S.D. of three independent yeast
colonies transformed by each set of bait and prey constructs.
C, localization of the interaction regions in PICT and
vimentin. P1CT constructs in vector pLexA and vimentin constructs in
pB42 are presented schematically. The coiled-coil regions are
shown in black. The numbers represent the amino
acid positions at the ends of the constructs. Note that mouse
polycystin-1 is 4329 amino acids long. Interaction was examined by
colony lift assay (quantified using -galactosidase
( -Gal)) as well as by the growth of yeast transformants
on plates lacking Trp, Ura, His, and Leu (LEU).
D, specificity of P1CT interaction with coiled-coil segments
of various proteins. The numbers indicate the amino acid
boundaries of each construct. Vim, vimentin.
|
|
P1CT-Vimentin Interactions Are Mediated through the Coiled-coil
Segments in Each Protein--
Most of the sequence in the vimentin
clone identified in the yeast two-hybrid screen was in a coiled-coil
region. To determine whether the interaction between P1CT and vimentin
was mediated by coiled-coil sequences present in both proteins, we
tested the interaction of a set of deletion constructs for both P1CT
and vimentin using yeast two-hybrid assays (Fig. 1C).
Deletion of the coiled-coil sequence from either parental construct
abolished the galactose-induced -galactosidase activity and resulted
in the failure of yeast transformants to grow in medium lacking
leucine. In contrast, deletion of non-coiled-coil regions had no
effect. We conclude that the interaction between P1CT and vimentin is mediated by the respective coiled-coil segments.
The coiled-coil motif of polycystin-1 was found previously to interact
with polycystin-2 (32, 35), RGS7 (21), and PBP-1 (34). The
identification of yet another coiled-coil protein interacting with the
coiled-coil motif of P1CT raised the concern that P1CT may have a
nonspecific affinity for coiled-coil sequences. To evaluate this
possibility, we tested the ability of P1CT to interact with several
additional coiled-coil proteins, some being components of various
junctional complexes where polycystin-1 was reportedly present. These
included CD2AP, axin, occludin, kinesin, and conductin. CD2AP interacts
with polycystin-2 (16) and with itself (Fig. 1D) through its
coiled-coil region. However, it did not interact with P1CT. Axin, a
protein involved in the Wnt/ -catenin signaling pathway, contains two
coiled-coil regions, the C-terminal of which (from residue 831) is
required for self-dimerization (36) and therefore serves as a positive
control. Although axin self-interaction was evident, no interaction
with P1CT was again detected. P1CT similarly did not interact with
occludin, a tight-junction protein (17), and conductin (19), an axin
homolog, and bound only weakly to kinesin (37), a motor protein
associated with microtubules. Thus despite the abundance of coiled-coil
proteins present at cell membranes, the fidelity of coiled-coil
interactions is apparently maintained by specific sequences within
P1CT. The ability of a coiled-coil region in one protein to interact
with multiple partners has been previously observed in other systems. For example, the same coiled-coil motifs of syntaxin mediate
interactions with different SNARE proteins (including syntaxin itself)
at different steps of membrane fusion and protein trafficking (38). The
multiple interactions mediated by the coiled-coil segment of P1CT may
similarly serve sequential steps in a single pathway or different
functions depending on the cell type.
P1CT Also Interacts with Epithelial and Muscle IF
Proteins--
Vimentin belongs to the intermediate filament protein
family (39). IFs in different tissues are comprised of different IF proteins. All IF proteins share the same molecular architecture, each
consisting of an N-terminal "head," a highly conserved central coiled-coil rod, and a C-terminal tail (Fig.
2A) (40). The central coiled-coil rod is separated by a nonhelical linker into two regions, helix 1 and helix 2. In vivo, IF proteins are assembled into
10-nm insoluble filaments. IF tetramers are considered to be the
building blocks for the higher order filament structure (41). A
tetramer is formed from two anti-parallel strands of head-to-tail
dimers, arranged in a staged manner; its longitudinal elongation and
lateral bundling give rise to the final IF structures. In this assembly scheme, one helix of the coiled-coil rod of an IF protein would be
exposed at the end of a filament.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
P1CT also interacts with IF proteins
cytokeratins and desmin. A, schematic representation of
an IF protein and a model for formation of an IF tetramer. Each
individual IF protein is composed of a central coiled-coil rod flanked
by a globular head (H) and tail (T) domains. The
central rod is separated by a nonhelical linker into helix 1 (black) and helix 2 (gray). A tetramer is formed
by aligning two head-to-tail dimers in an anti-parallel, staged manner.
Note that the model predicts that one helix of an IF protein would be
exposed if it is located at the ends of a filament. B and
C, examination of interaction of P1CT with different IF
proteins by yeast two-hybrid analysis. Each IF protein was constructed
in vector pB42 in three forms: one containing head and helix 1, another
containing helix 2 and the tail, and the third containing the whole
protein. The choice of the N-terminal amino acid is determined by the
availability of a quality oligonucleotide for a PCR reaction.
Each construct was co-transformed into yeast with pLexA-P1CT. The
transformants were plated on the synthetic medium containing galactose
but lacking His, Ura, and Trp. -Galactosidase ( -Gal)
activity was analyzed by colony lift assay on a filter at 30 °C
using X-gal as substrate. The negative control is not shown. Yeast did
not grow on plates transformed with the desmin full-length construct
(X). +, , and +/ indicate interaction, no interaction,
or borderline interaction, respectively. Vim, vimentin;
Des, desmin.
|
|
Vimentin is mainly expressed in mesenchymal and endothelial cells (39).
Other IF proteins, on the other hand, have different tissue-specific
expression patterns; cytokeratins K8 and K18 are expressed in simple
epithelial cells, such as those lining kidney tubules, and desmin is a
muscle-specific IF protein. Because polycystin-1 is expressed in a wide
variety of tissues, some lacking vimentin, and the deficiency of
polycystin 1 affects endothelial as well as epithelial and muscle cell
functions, we determined whether P1CT interacts with cytokeratins K8
and K18 and desmin. We generated three constructs for each IF protein
(Fig. 2B); one encompasses the head domain and helix 1, the
second contains helix 2 and the tail, and the third spans the whole
protein. We examined the interaction of P1CT with each construct in
yeast two-hybrid assays. With the exception of the helix 1 construct of
cytokeratin 18 (K18 (1)), all single helix-containing constructs
interacted with P1CT. The failure of P1CT to interact with K18 helix 1 was not an artifact, because the same K18 prey construct was able to
interact with its in vivo partner K8 helix 1 (Fig.
2C). The results using full-length constructs were less
consistent. Although K8 and K18 displayed weak interaction, yeast did
not grow when transformed with the full-length desmin construct in pB42
vector. Full-length vimentin did not interact with P1CT but displayed
strong interaction with itself. This differential reactivity of
vimentin is likely the result of formation of mispaired IF protein
oligomers when the full-length protein is expressed in the pLexA/pB42
system and has been previously noted with IF proteins analyzed in the
yeast two-hybrid system (42).
In Vitro Interaction of P1CT with IF Proteins--
To establish
that P1CT interacts with the full-length IF proteins, we first carried
out GST pull-down analysis (Fig. 3,
A and B). A 77-amino acid peptide encompassing
the coiled-coil region of P1CT (P1CC) (Fig. 1A) was
expressed as a GST fusion protein in bacteria. The fusion protein was
immobilized on glutathione beads and incubated with cell lysate.
Proteins that bind to P1CC were analyzed by SDS-PAGE followed by
Western blotting. To assign IF proteins unambiguously, we FLAG-tagged
vimentin, desmin, and cytokeratins K8 and K18. We transfected HEK 293 cells with expression vector for FLAG-tagged vimentin or desmin. For
cytokeratins, we co-transfected both K8 and K18 into the same cells.
Fig. 3B shows the specific pull-down of K8, K18, vimentin,
and desmin by GST-P1CC but not by GST, indicating that P1CC interacted
with the IF proteins. The amount of K8 is less than that of K18 in the
K8/K18 panel, a reflection of the relative expression levels of the two
plasmid constructs (data not shown).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 3.
Interaction of P1CT with IF proteins.
A and B, GST pull-down of IF proteins by P1CC.
A, 10 µl of glutathione beads bound by GST or GST-P1CC
were resolved on 10% SDS-PAGE and stained with Coomassie Blue G-250.
B, specific binding of IF proteins to the GST-P1CC fusion
protein. Cell lysates from HEK 293 cells transfected with FLAG-tagged
K8/K18, vimentin, or desmin, were passed over GST or GST-P1CC beads,
and the proteins bound to the washed beads were resolved by 10%
SDS-PAGE and identified by Western blotting using anti-FLAG antibody as
probe. C, Coomassie Blue staining of the recombinant IF
proteins vimentin (V), desmin (D), and
cytokeratin K8/K18 heterodimer (K) following 10% SDS-PAGE.
D, Coomassie Blue-stained recombinant purified P1CC
(lane 1) and Western blot visualized-biotinylated P1CC
peptide (lane 2), as resolved on 10-20% SDS-PAGE.
E, dose-dependent co-sedimentation of
biotinylated-P1CC with IF filaments. P1CC was mixed with the respective
IF proteins at 0.001 and 0.01 molar ratios, before filament assembly
was initiated. Assembled filaments were sedimented by centrifugation,
and P1CC incorporation in the pellet was detected by Western blotting.
P1CC did not co-sediment in the presence of BSA even when used at
higher molar ratio of 0.5. Molecular mass markers (Bio-Rad)
shown are those for bovine serum albumin (66 kDa), ovalbumin (45 kDa),
carbonic anhydrase (31 kDa), lysozyme (14.4 kDa), and aprotinin (6.5 kDa).
|
|
In vitro filament assembly studies further confirmed the
interaction of P1CT with IF (Fig. 3, C-E). IF assembly was
done by stepwise dialysis of the recombinant proteins into a high
pH/low salt buffer (39), under which condition the IF proteins exist mainly as tetrameric protofilaments. After the addition of biotinylated P1CC, followed by a 1-h incubation, filament assembly was initiated by
adjusting pH and salt concentration, and the filaments were collected
by ultracentrifugation followed by Western blotting. As shown in Fig.
3E, P1CC co-sedimented with vimentin, desmin, and
cytokeratins K8/K18, and incorporation increased with higher concentration of P1CC in the assembly reaction. No P1CC was pelleted in
the presence or absence of BSA under these conditions, indicating that
the presence of P1CC in the IF co-sediment is not due to self-aggregation. Consistently, we found that the co-sedimentation of
P1CC with K8/K18 was lower than with vimentin or desmin. This may be
caused by different assembly kinetics for cytokeratins and/or by
different assembly conditions (43). Increasing the P1CC concentration
further did not significantly increase the incorporation, suggesting
that binding was saturated (data not shown).
We also tested whether P1CC bound to preassembled IFs by incubation of
IF with P1CC after filament assembly. No binding of P1CC to IFs was
detected (data not shown). Together, these results indicated that
binding of P1CC to soluble forms of IF proteins was required for the
incorporation of P1CC into filaments in vitro. The fact that
binding was saturable at a P1CC/IF molar ratio of 0.01 suggests that
P1CC bound to unoccupied coiled-coil domains at ends of assembled
filaments, consistent with the general filament assembly scheme (Fig.
2A).
The Coiled-coil Region of Polycystin-1 Mediates Its Association
with the Cytoskeleton--
The interaction of P1CT with IFs predicts
that polycystin-1 would be in the Triton X-100 insoluble cytoskeleton
fraction (27) as was previously reported (12). Our findings further
suggested that this association is mediated by the coiled-coil region
of polycystin-1. To test this, we made a set of three membrane-anchored P1CT constructs, each as a fusion protein of sIg extracellular domain,
CD7 transmembrane span, and a P1CT variant (Fig.
4). Each construct was tagged by a FLAG
epitope at the C terminus. We transiently transfected the constructs
into HEK 293 or HeLa cells. Two days later, the cells were lysed in the
cytoskeleton stabilizing buffer. The distribution of each construct in
the detergent-soluble and -insoluble fractions was compared. With the
full-length cytoplasmic tail construct, the majority of the fusion
protein was found in the detergent-insoluble fraction of HEK 293 cells.
The same was true for the truncation construct that contained an intact
coiled-coil region. When the coiled-coil region was deleted, the
protein distribution shifted to the soluble fraction. The results in
the HeLa cell line were identical. Increasing the NaCl concentration up
to 0.6 M in the extraction buffer was not sufficient to
fully release P1CT from the insoluble fraction (data not shown).
Together, these data indicate that the coiled-coiled region of
polycystin-1 mediates its association with the cytoskeleton fraction.
The persistence of full-length P1CT in this fraction after high salt
extraction strongly suggests that at least a portion of the P1CT fusion
protein is tightly associated with IFs.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 4.
Coiled-coil region of polycystin-1 mediates
the association with cytoskeleton. A, schematic
representation of the membrane-anchored P1CT fusion constructs. Each
construct contains the extracellular domain of sIgG, CD7 transmembrane
segment (in gray) and native or shorter versions of P1CT. A
FLAG epitope was added to the C terminus. The coiled-coil region is
shown in black. B, the coiled-coil region is
required for the association of P1CT with cytoskeleton. HEK 293 cells
were transfected with each construct and lysed in the cytoskeleton
stabilization buffer 2 days later. The distribution of each construct
in the soluble lysate and in the cytoskeleton pellet was analyzed by
Western blotting using the anti-FLAG antibody. Molecular mass markers
(Bio-Rad) shown are those for ovalbumin (45 kDa) and bovine serum
albumin (66 kDa).
|
|
The P1CT Fusion Construct Decorates Cytokeratin Filaments in
LLC-PK1 Cells--
To further substantiate P1CT-IF interaction, we set
out to examine the cellular localization of the membrane-anchored P1CT fusion construct in transfected cells. This approach was previously used to validate the interaction of a desmoplakin fragment with IFs
(25). We transfected the kidney epithelial cells LLC-PK1 with
pCD16.7PKD115-226, a fusion construct containing the CD16 extracellular epitope, a CD7 transmembrane domain, and the C-terminal 112 amino acids of P1CT, which includes the coiled-coil domain (21).
Cells transfected with a control CD16.7 vector showed a diffuse
speckled pattern of perinuclear cytoplasmic and some surface membrane
CD16 staining (Fig. 5). Strikingly, cells
transfected with pCD16.7PKD115-226 invariably displayed a filamentous
intracellular pattern of CD16 staining, decorating what could be
cytokeratin filaments or microtubule networks. To distinguish between
these two possibilities, we treated pCD16.7PKD115-226 expressing cells with nocodazole, a potent microtubule-disrupting reagent (44) that
depolymerizes the microtubule network and causes deformation/collapse of IFs around nuclei, as a result of loss of connection of IF filaments
to microtubules (45). Nocodazole treatment totally depolymerized
microtubules, as assessed by immunofluorescence (data not shown).
However, the filamentous distribution of CD16 remained and predictably
showed a partial collapse of the filaments into a perinuclear ring,
characteristic of the response of IFs to depolymerization of
microtubules with which they associate (45). These data indicate that
P1CT is capable of mediating the association with IFs when
overexpressed in living cells.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
P1CT fusion construct decorates keratin
filaments in LLC-PK1 cells. The subcellular expression pattern of
the human P1CT fusion construct pCD16.7 PKD 115-226 in LLC-PK1 cells.
A, the control CD16 fusion protein encoded by pCD16.7
distributed mainly in the cytoplasmic vesicles and the perinuclear
region with some plasma membrane localization. B, P1CT-CD16
fusion protein displayed a filamentous pattern of distribution.
C, cells expressing P1CT-CD16 fusion protein as in
B were treated with nocodazole for 1 h before staining.
The P1CT fusion construct showed a collapsed filamentous pattern of
expression that is characteristic of IF filaments. Scale
bar, 5 µm.
|
|
Distribution and Kinetics of Association of Endogenous Polycystin-1
with Keratin Filament at Desmosomal Junctions--
We next examined
the subcellular distribution of endogenous polycystin-1 in relation to
IFs and desmosomes. Because abnormal kidney function is an invariable
feature of ADPKD, we examined the co-distribution of polycystin-1,
cytokeratins, and desmoplakin in a cell line from this tissue. We
initially carried out immunostaining on MDCK cells using monospecific
antibodies directed against polycystin-1 and cytokeratins.
Polycystin-1-dependent staining revealed discrete nodular
junctional staining, together with some cytoplasmic staining; nuclear
staining was also observed, a nonspecific feature previously found
using this antibody (6). The antibody against cytokeratin revealed an
extensive filamentous network that surrounded the nuclei and radiated
into the desmosomal cell-cell junctions. Superimposing polycystin-1 and
cytokeratin staining revealed a striking overlap at the cell junctions,
which also overlapped with desmoplakin staining when all three
antibodies were used simultaneously (Fig. 6). To quantify the extent of
polycystin-1/cytokeratin co-localization, we counted the frequency of
polycystin-1 junctional staining in areas of cell-cell contact where
keratin filaments could clearly be identified converging on the cell
membranes between neighboring cells. Of 232 desmosomes (double-labeled
with cytokeratin and desmoplakin), 217 (93.5%) showed discrete foci of
polycystin-1 staining. The kinetics of appearance of polycystin-1 at
desmosomal junctions was also examined in cultured MDCK cells using
calcium switch experiments. We found that desmoplakin was present in
membrane junctions 30 min after replenishment of calcium in MDCK
cultures, and at 120 min, both polycystin-1 and desmoplakin were
present in desmosomes (data not shown). Similar kinetics were recently reported by Scheffers et al. (9)

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 6.
Endogenous polycystin-1 is linked to keratin
filaments at desmosomal junctions. MDCK cells stained with
antibodies against pan-cytokeratins (A), polycystin-1
(B), and desmoplakin I and II. C shows the
superimposition of A and B, and D
shows the staining pattern obtained with all three antibodies.
E-H are magnified presentations of the staining in the
bottom right corner for each upper panel. Note
that polycystin-1 is distributed as discrete nodules linked to keratin
filaments (arrows) and co-localized with desmoplakins
(D and H). This experiment was repeated by two
individuals a total of four times. A-D, scale
bar, 5 µm; E-H, scale bar, 1.25 µm.
|
|
 |
DISCUSSION |
The studies presented in this paper identify a direct interaction
between polycystin-1 and the intermediate filament network. We present
four independent observations that document this interaction and its
specificity. First, an unbiased search of an epithelial cell library
for P1CT-interacting proteins identified vimentin as a strong
interactant. We extended this observation to cytokeratins 8 and 18 and
desmin, specialized IF proteins of epithelium, and muscle cells,
respectively. Interaction required the coiled-coil motif of each
partner. Second, P1CT interacted with full-length IF proteins in GST
pull-down and in in vitro filament assembly experiments.
Third, membrane-anchored P1CT associated with the Triton
X-100-insoluble cytoskeleton fraction through its coiled-coil segment.
Finally, P1CT decorated IFs, and native polycystin-1 distributed with
cytokeratins at desmosomal junctions in MDCK cells. These observations
are strong evidence of a direct polycystin-1-IF interaction both
in vitro and in vivo.
Membrane-anchored P1CT decorated the cytoplasmic IF network, whereas
native polycystin-1 was localized in association with IF at desmosomes.
This difference in subcellular distribution between a native protein
and a recombinant fragment thereof has been observed previously. For
example, the recombinant IF-interacting domain of desmoplakin has been
shown to decorate cytoplasmic IFs, in contrast to the desmosomal
localization of the intact protein (25). This difference in
distribution may relate to the presence of additional domains in the
native protein that may target it differently. Alternatively,
overexpression of the recombinant fragment may saturate binding sites
in IFs, which may only be available to the native protein under certain conditions.
The present data also show that P1CT interacts with IF subunits (Figs.
1, 2, and 3B) as well as with assembled IFs (Figs. 3E, 5, and 6). Because assembly of IF subunits into polymers
is driven by the coiled-coil domain, these data raise the logical question of how P1CT can bind to assembled IFs in vivo. The
assembled IF tetramer, schematically depicted in Fig. 2A,
shows that the coiled-coil domains of IFs are exposed at the ends of
the soluble tetramers; these are the expected sites of binding to P1CT.
P1CT-IF interaction appears therefore to be different from other IF
interactions such as those between vimentin and fimbrin (46); in the
latter case the nonhelical domain of vimentin mediates the binding. An additional feature of IF that may help explain why P1CT can bind IF
in vivo is the fact that IF assembly/disassembly is a
dynamic process; helical domains are exposed as IFs continuously
remodel in vivo. This has been clearly demonstrated with
fluorescence recovery after photobleaching analysis of
GFP-vimentin expressing cells where fluorescence recovery occurs
rapidly in the middle of bleached vimentin filaments without the
translation of the gap in fluorescence to the ends of the filament
(47). We suggest that the association of the polycystin-1 represents
incorporation into the sides of the continuously remodeled intermediate filaments.
The localization of polycystin-1 at desmosomal junctions revealed in
the present study is further supported by the congruent distribution of
desmosomes and polycystin-1 in normal adult mouse kidney. In a
systematic study of the expression of junctional proteins along the
nephron, Piepenhagen and Nelson (48) found that the distribution of
E-cadherin and and catenins is uniform in all nephron segments
and that E-cadherin and and catenins are present along the
entire length of the lateral cell membranes. In contrast,
expression of the desmosomal marker desmoplakin is restricted to the
distal nephron (beginning with the thick ascending loop of Henle, the
distal convoluted and collecting tubules and collecting ducts), with
the highest expression between the distal convoluted tubule and
collecting ducts. Plakoglobin and cytokeratin K8, two other components
of desmosomes, were strongly expressed in the same segments. The
subcellular distribution of desmosomes was also segment-specific;
desmoplakin was restricted to the apical-lateral membranes,
co-localizing with ZO-1 in the distal convoluted tubules. In collecting
tubules, desmoplakin was distributed to both lateral and basal
membranes. The expression profile of desmoplakin and cytokeratin
matches that of polycystin-1, which in adult kidney is also found in
the thick ascending loop of Henle, the distal convoluted tubule, and
most abundantly in collecting ducts with a predominant lateral
junctional distribution (8, 49).
The desmosome is a distinctive structure that tethers IFs to the plasma
membrane and is most prominent in tissues exposed to mechanical stress
(reviewed in Refs. 50 and 51). It is characterized by two parallel
electron dense cytoplasmic plaques lying on either side of two adjacent
plasma membranes that are separated by an intercellular electron-dense
zipper-like midline. The latter is formed of desmosomal cadherins from
apposing cells interacting homo- or heterotypically. Desmosomal
junctions are the most specialized of vertebrate junctions and arose
after adherens junctions in metazoan evolution; they also form after
adherens junctions both during development and in cells that are
induced to make junctions (reviewed in Ref. 51). In epithelial cells, desmosomal cadherins are linked to IFs mainly through plakoglobin and
plakophillins (which, like -catenin, are members of the armadillo family of nuclear and junctional proteins) and
desmoplakins. Interaction among these proteins occurs in series:
desmosomal cadherin-plakoglobin-desmoplakin-IF, mirroring protein
interactions at adherens junctions (classic cadherins- - -catenins-microfilaments), or laterally
(e.g. cadherin-desmoplakin-IF; cadherin-plakophilin-IF).
Connections also exist across junctions (e.g.
E-cadherin-plakoglobin; desmosomal cadherin- -catenin;
plakoglobin- -catenin), underscoring a close relationship between
desmosomes and adherens junctions. In endothelial cells, which lack
desmosomal cadherins, cadherins form hybrid junctional complexes
linking to both IFs and microfilaments.
Our immunolocalization of endogenous polycystin-1 to desmosomes in
epithelium and the supportive electron microscopy data of
Scheffers et al. (9) also brings the question of how
polycystin-1-IF interaction is possible at desmosomes, given the
relatively short length of the polycystin-1 C-tail and the potential
dense barrier to cell surface provided by the plaque proteins. One
possibility is that IF may penetrate the plaque en route to the plasma
membrane as previously reported (50, 52, 53). It has also been shown that plakophilin, which interacts directly with IF proteins, is localized very close to the plasma membrane in the desmosomal plaque
(54); an analogous situation may apply to polycystin-1. Alternatively,
polycystin-1 may be localized at the periphery of desmosomes; IF
converge at desmosomal plaques (55), and some may loop away toward the
periphery, perhaps permitting additional interactions with other
proteins such as polycystin-1.
The interaction of polycystin-1 with IF may serve several functions.
First, expression of desmoplakin, cytokeratin K8, and polycystin-1 in
normal adult kidney is high in the distal half of the nephron where the
degree of lateral membrane interdigitations between tubular epithelial
cells is low. In this segment, paracellular conductances are low, and
therefore the osmotic stress is high. An interdigitated lateral
membrane and/or a well developed IF network and desmosomal junctions
would render cells more resistant to deformation and other forms of
physical stress. Polycystin-1 may contribute to the strengthening of
lateral junctions, particularly in tissues where desmosomes are lacking
as in endothelium. It is less likely that polycystin-1 is involved in
initiating the formation of desmosomes because the phenotypes of mice
with homozygous disruption of polycystin-1 or the desmosomal core
protein desmoplakin are different (embryonic lethality occurs earlier
before kidneys begin to form, when desmoplakin is disrupted (56)).
Also, in calcium switch experiments, the appearance of polycystin-1 at lateral junctions follows that of desmoplakin. This observation may
account for the different phenotypes in the knockout animals (reviewed
in Ref. 51) and suggests that polycystin-1 plays a maintenance rather
than an initiation role at desmosomes
Second, localization of polycystin-1 at desmosomes may be crucial for
its signaling functions. P1CT, the region shown here to associate with
IF, binds directly to P2CT, 14-3-3 (31), G-proteins (57), and RGS7
(21), enhances cellular ion channel activity (58, 59), and is modulated
by serine and tyrosine kinases (60, 61) (Fig. 1A). Also,
expression in epithelial cells of membrane-anchored P1CT, the form
shown here decorating IF, stimulates AP-1-dependent gene
transcription via the JNK pathway (through activation of
rac-1/cdc-42/protein kinase C (33) and TCF-mediated gene transcription
via the Wnt pathway (21). Like adherens junctions, desmosomes are sensitive to growth factors (62), intracellular calcium
(63), and protein kinase C (64) and are linked to the Wnt
signaling pathway (50). In addition, IFs have been implicated in cell
cycle regulation, differentiation (65), and cell migration (66), roles
already claimed for polycystin-1 (67). Perhaps relevant in this regard
is that desmosomes appear to have arisen relatively late in evolution,
leading to the suggestion that their signaling functions may contribute
to later stages of cellular differentiation (51).
Third, polycystin-1 is not only found in the plasma membrane but has
also been detected in the cytoplasm (9, 68, 69) (Fig. 6). The transport
of polycystin-1 to the lateral plasma membrane requires tuberin (13), a
GTPase-activating protein for Rap1 (70) and Rab5 (71). Polycystin-1 has
also been shown to assist in the transport of polycystin-2 to the cell
surface (59). The IF vimentin has been reported recently to serve as a
reservoir for the cell trafficking protein SNAP23 (72). Vimentin may
play a similar role for polycystin-1. The presence of polycystin-1 foci
that are associated with neither keratin filaments nor desmoplakin (Fig. 6) may reflect the presence of an additional intracellular polycystin-1 pool with distinct intramolecular associations. Failure to
deliver polycystins to cell membranes, caused either by a
malfunctioning protein (73), by interference with a trafficking protein
(e.g. tuberin), or by overexpression of multi-copy
polycystin-1 (74) may contribute to the variable disease phenotype in
ADPKD.
 |
FOOTNOTES |
*
This work is supported by National Institutes of Health
Grant P01 DK54711.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a National Institutes of Health training grant.
§
Supported by a National Kidney Foundation research fellowship.
¶
To whom correspondence should be addressed: Renal Unit,
Massachusetts General Hospital, Bldg. 149, 13th St., Charlestown, MA
02129. Tel.: 617-726-5663; Fax: 617-726-5671; E-mail:
arnaout@receptor.mgh.harvard.edu.
Published, JBC Papers in Press, October 1, 2001, DOI 10.1074/jbc.M107828200
 |
ABBREVIATIONS |
The abbreviations used are:
ADPKD, autosomal
dominant polycystic kidney disease;
PCR, polymerase chain reaction;
MDCK, Madin-Darby canine kidney;
X-gal, 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside;
GST, glutathione
S-transferase;
BSA, bovine serum albumin;
IF, intermediate
filament;
P1CT, polycystin-1 C-tail;
PAGE, polyacrylamide gel
electrophoresis;
FBS, fetal bovine serum;
P1CC, coiled-coil region of
P1CT;
Pipes, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Arnaout, M. A.
(2001)
Annu. Rev. Med.
52,
93-123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
The European Polycystic Kidney Disease Consortium.
(1994)
Cell
77,
881-894[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
The International Polycystic Kidney Disease Consortium.
(1995)
Cell
81,
289-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kim, K.,
Drummond, I.,
Ibraghimov-Beskrovnaya1, O.,
Klinger, K.,
and Arnaout, M. A.
(2000)
Proc. Nat'l Acad. Sci. U. S. A.
97,
1731-1736[Abstract/Free Full Text]
|
| 5.
|
Lu, W.,
Peissel, B.,
Babakhanlou, H.,
Pavlova, A.,
Geng, L.,
Fan, X.,
Larson, C.,
Brent, G.,
and Zhou, J.
(1997)
Nat. Genet.
17,
179-181[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Ibraghimov-Beskrovnaya, O.,
Dackowski, W. R.,
Foggensteiner, L.,
Coleman, N.,
Thiru, S.,
Petry, L. R.,
Burn, T. C.,
Connors, T. D.,
Van Raay, T.,
Bradley, J.,
Qian, F.,
Onuchic, L. F.,
Watnick, T. J.,
Piontek, K.,
Hakim, R. M.,
Landes, G. M.,
Germino, G. G.,
Sandford, R.,
and Klinger, K. W.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6397-6402[Abstract/Free Full Text]
|
| 7.
|
Huan, Y.,
and van Adelsberg, J.
(1999)
J. Clin. Invest.
104,
1459-1468[Medline]
[Order article via Infotrieve]
|
| 8.
|
Foggensteiner, L.,
Bevan, A. P.,
Thomas, R.,
Coleman, N.,
Boulter, C.,
Bradley, J.,
Ibraghimov-Beskrovnaya, O.,
Klinger, K.,
and Sandford, R.
(2000)
J. Am. Soc. Nephrol.
11,
814-827[Abstract/Free Full Text]
|
| 9.
|
Scheffers, M. S.,
van der Bent, P.,
Prins, F.,
Spruit, L.,
Breuning, M. H.,
Litvinov, S. V.,
de Heer, E.,
and Peters, D. J.
(2000)
Hum. Mol. Genet.
9,
2743-2750[Abstract/Free Full Text]
|
| 10.
|
Brown, D.,
Rabb, H.,
Sharma, P.,
McLaughlin, M.,
and Arnaout, A.
(1998)
J. Am. Soc. Nephrol.
9,
371 (abstr.)
|
| 11.
|
Wilson, P. D.,
Geng, L.,
Li, X.,
and Burrow, C. R.
(1999)
Lab. Invest.
79,
1311-1323[Medline]
[Order article via Infotrieve]
|
| 12.
|
Peters, D. J.,
van de Wal, A.,
Spruit, L.,
Saris, J. J.,
Breuning, M. H.,
Bruijn, J. A.,
and de Heer, E.
(1999)
J. Pathol.
188,
439-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kleymenova, E.,
Ibraghimov-Beskrovnaya, O.,
Kugoh, H.,
Everitt, J.,
Xu, H.,
Kiguchi, K.,
Landes, G.,
Harris, P.,
and Walker, C.
(2001)
Mol. Cell
7,
823-832[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Meng, J. J.,
Khan, S.,
and Ip, W.
(1994)
J. Biol. Chem.
269,
18679-18685[Abstract/Free Full Text]
|
| 15.
|
Inada, H.,
Goto, H.,
Tanabe, K.,
Nishi, Y.,
Kaibuchi, K.,
and Inagaki, M.
(1998)
Biochem. Biophys. Res. Commun.
253,
21-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Lehtonen, S.,
Ora, A.,
Olkkonen, V. M.,
Geng, L.,
Zerial, M.,
Somlo, S.,
and Lehtonen, E.
(2000)
J. Biol. Chem.
275,
32888-32893[Abstract/Free Full Text]
|
| 17.
|
Ando-Akatsuka, Y.,
Saitou, M.,
Hirase, T.,
Kishi, M.,
Sakakibara, A.,
Itoh, M.,
Yonemura, S.,
Furuse, M.,
and Tsukita, S.
(1996)
J. Cell Biol.
133,
43-47[Abstract/Free Full Text]
|
| 18.
|
Zeng, L.,
Fagotto, F.,
Zhang, T.,
Hsu, W.,
Vasicek, T. J.,
Perry, W. L., 3rd,
Lee, J. J.,
Tilghman, S. M.,
Gumbiner, B. M.,
and Costantini, F.
(1997)
Cell
90,
181-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Behrens, J.,
Jerchow, B. A.,
Wurtele, M.,
Grimm, J.,
Asbrand, C.,
Wirtz, R.,
Kuhl, M.,
Wedlich, D.,
and Birchmeier, W.
(1998)
Science
280,
596-599[Abstract/Free Full Text]
|
| 20.
|
Gudkov, A. V.,
Kazarov, A. R.,
Thimmapaya, R.,
Axenovich, S. A.,
Mazo, I. A.,
and Roninson, I. B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3744-3748[Abstract/Free Full Text]
|
| 21.
|
Kim, E.,
Arnould, T.,
Sellin, L. K.,
Benzing, T.,
Fan, M. J.,
Gruning, W.,
Sokol, S. Y.,
Drummond, I.,
and Walz, G.
(1999)
J. Biol. Chem.
274,
4947-4953[Abstract/Free Full Text]
|
| 22.
|
Neophytou, P.,
Constantinides, R.,
Lazarou, A.,
Pierides, A.,
and Deltas, C. C.
(1996)
Hum. Genet.
98,
437-442[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Perrichot, R.,
Mercier, B.,
Carre, A.,
Cledes, J.,
and Ferec, C.
(2000)
Hum. Mutat.
15,
582
|
| 24.
|
Nagai, K.,
and Thogersen, H. C.
(1987)
Methods Enzymol.
153,
461-481[Medline]
[Order article via Infotrieve]
|
| 25.
|
Kouklis, P. D.,
Hutton, E.,
and Fuchs, E.
(1994)
J. Cell Biol.
127,
1049-1060[Abstract/Free Full Text]
|
| 26.
|
Herrmann, H.,
Strelkov, S. V.,
Feja, B.,
Rogers, K. R.,
Brettel, M.,
Lustig, A.,
Haner, M.,
Parry, D. A.,
Steinert, P. M.,
Burkhard, P.,
and Aebi, U.
(2000)
J. Mol. Biol.
298,
817-832[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Hinck, L.,
Nathke, I. S.,
Papkoff, J.,
and Nelson, W. J.
(1994)
J. Cell Biol.
125,
1327-1340[Abstract/Free Full Text]
|
| 28.
|
Gyuris, J.,
Golemis, E.,
Chertkov, H.,
and Brent, R.
(1993)
Cell
75,
791-803[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Sandford, R.,
Sgotto, B.,
Aparicio, S.,
Brenner, S.,
Vaudin, M.,
Wilson, R. K.,
Chissoe, S.,
Pepin, K.,
Bateman, A.,
Chothia, C.,
Hughes, J.,
and Harris, P.
(1997)
Hum. Mol. Genet.
6,
1483-1489[Abstract/Free Full Text]
|
| 30.
|
Ferrari, S.,
Battini, R.,
Kaczmarek, L.,
Rittling, S.,
Calabretta, B.,
de Riel, J. K.,
Philiponis, V.,
Wei, J. F.,
and Baserga, R.
(1986)
Mol. Cell. Biol.
6,
3614-3620[Abstract/Free Full Text]
|
| 31.
|
Kim, K.,
Sharma, C.,
and Arnaout, M.
(1997)
J. Am. Soc. Nephrol.
8,
375 (abstr.)
|
| 32.
|
Qian, F.,
Germino, F. J.,
Cai, Y.,
Zhang, X.,
Somlo, S.,
and Germino, G. G.
(1997)
Nat. Genet.
16,
179-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Kim, E.,
Arnould, T.,
Sellin, L.,
Benzing, T.,
Comella, N.,
Kocher, O.,
Tsiokas, L.,
Sukhatme, V. P.,
and Walz, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6371-6376[Abstract/Free Full Text]
|
| 34.
|
Qian, E.,
Germino, J.,
Zhang, X. B.,
and Germino, G. G.
(1997)
J. Am. Soc. Nephrol.
8,
1753 (abstr.)
|
| 35.
|
Tsiokas, L.,
Kim, E.,
Arnould, T.,
Sukhatme, V. P.,
and Walz, G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6965-6970[Abstract/Free Full Text]
|
| 36.
|
Hsu, W.,
Zeng, L.,
and Costantini, F.
(1999)
J. Biol. Chem.
274,
3439-3445[Abstract/Free Full Text]
|
| 37.
|
Thormahlen, M.,
Marx, A.,
Sack, S.,
and Mandelkow, E.
(1998)
J Struct. Biol.
122,
30-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Carr, C. M.,
and Novick, P. J.
(2000)
Nature
404,
347-349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Herrmann, H.,
and Aebi, U.
(2000)
Curr. Opin. Cell Biol.
12,
79-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Fuchs, E.
(1997)
Mol. Biol. Cell
8,
189-203[Abstract]
|
| 41.
|
Coulombe, P. A.,
and Fuchs, E.
(1990)
J. Cell Biol.
111,
153-169[Abstract/Free Full Text]
|
| 42.
|
Leung, C. L.,
and Liem, R. K.
(1996)
J. Biol. Chem.
271,
14041-14044[Abstract/Free Full Text]
|
| 43.
|
Herrmann, H.,
Haner, M.,
Brettel, M.,
Ku, N.,
and Aebi, U.
(1999)
J. Mol. Biol.
286,
1403-1420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Vasquez, R. J.,
Howell, B.,
Yvon, A. M.,
Wadsworth, P.,
and Cassimeris, L.
(1997)
Mol. Biol. Cell
8,
973-985[Abstract]
|
| 45.
|
Ho, C. L.,
Martys, J. L.,
Mikhailov, A.,
Gundersen, G. G.,
and Liem, R. K.
(1998)
J. Cell Sci.
111,
1767-1778[Abstract]
|
| 46.
|
Correia, I.,
Chu, D.,
Chou, Y. H.,
Goldman, R. D.,
and Matsudaira, P.
(1999)
J. Cell Biol.
146,
831-842[Abstract/Free Full Text]
|
| 47.
|
Yoon, M.,
Moir, R. D.,
Prahlad, V.,
and Goldman, R. D.
(1998)
J. Cell Biol.
143,
147-157[Abstract/Free Full Text]
|
| 48.
|
Piepenhagen, P. A.,
and Nelson, W. J.
(1995)
Am. J. Physiol.
269,
C1433-C1449[Abstract/Free Full Text]
|
| 49.
|
Ong, A. C.,
Ward, C. J.,
Butler, R. J.,
Biddolph, S.,
Bowker, C.,
Torra, R.,
Pei, Y.,
and Harris, P. C.
(1999)
Am. J. Pathol.
154,
1721-1729[Abstract/Free Full Text]
|
| 50.
|
Kowalczyk, A. P.,
Bornslaeger, E. A.,
Norvell, S. M.,
Palka, H. L.,
and Green, K. J.
(1999)
Int. Rev. Cytol.
185,
237-302[Medline]
[Order article via Infotrieve]
|
| 51.
|
Green, K. J.,
and Gaudry, C. A.
(2000)
Nat. Rev. Mol. Cell. Biol.
1,
208-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
McNutt, N. S.,
and Weinstein, R. S.
(1973)
Prog. Biophys. Mol. Biol.
26,
45-101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Kelly, D. E.,
and Kuda, A. M.
(1981)
Anat. Rec.
199,
1-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
North, A. J.,
Bardsley, W. G.,
Hyam, J.,
Bornslaeger, E. A.,
Cordingley, H. C.,
Trinnaman, B.,
Hatzfeld, M.,
Green, K. J.,
Magee, A. I.,
and Garrod, D. R.
(1999)
J. Cell Sci.
112,
4325-4336[Abstract]
|
| 55.
|
Garrod, D. R.
(1993)
Curr. Opin. Cell Biol.
5,
30-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Gallicano, G. I.,
Kouklis, P.,
Bauer, C.,
Yin, M.,
Vasioukhin, V.,
Degenstein, L.,
and Fuchs, E.
(1998)
J. Cell Biol.
143,
2009-2022[Abstract/Free Full Text]
|
| 57.
|
Parnell, S. C.,
Magenheimer, B. S.,
Maser, R. L.,
Rankin, C. A.,
Smine, A.,
Okamoto, T.,
and Calvet, J. P.
(1998)
Biochem. Biophys. Res. Commun.
251,
625-631[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Vandorpe, D. H.,
Chernova, M. N.,
Jiang, L.,
Sellin, L. K.,
Wilhelm, S.,
Stuart-Tilley, A. K.,
Walz, G.,
and Alper, S. L.
(2001)
J. Biol. Chem.
276,
4093-4101[Abstract/Free Full Text]
|
| 59.
|
Hanaoka, K.,
Qian, F.,
Boletta, A.,
Bhunia, A. K.,
Piontek, K.,
Tsiokas, L.,
Sukhatme, V. P.,
Guggino, W. B.,
and Germino, G. G.
(2000)
Nature
408,
990-994[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Parnell, S. C.,
Magenheimer, B. S.,
Maser, R. M.,
and Calvet, J. P.
(1999)
Biochem. Biophys. Res. Commun.
259,
539-543[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Li, H.-P.,
Geng, L.,
Burrow, C. R.,
and Wilson, P. D.
(1999)
Biochem. Biophys. Res. Commun.
259,
356-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 62.
|
Savagner, P.,
Yamada, K. M.,
and Thiery, J. P.
(1997)
J. Cell Biol.
137,
1403-1419[Abstract/Free Full Text]
|
| 63.
|
Jones, J. C.,
and Goldman, R. D.
(1985)
J. Cell Biol.
101,
506-517[Abstract/Free Full Text]
|
| 64.
|
Sheu, H. M.,
Kitajima, Y.,
and Yaoita, H.
(1989)
Exp. Cell Res.
185,
176-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Allen, E., Yu, Q. C.,
and Fuchs, E.
(1996)
J. Cell Biol.
133,
1367-1382[Abstract/Free Full Text]
|
| 66.
|
Eckes, B.,
Dogic, D.,
Colucci-Guyon, E.,
Wang, N.,
Maniotis, A.,
Ingber, D.,
Merckling, A.,
Langa, F.,
Aumailley, M.,
Delouvee, A.,
Koteliansky, V.,
Babinet, C.,
and Krieg, T.
(1998)
J. Cell Sci.
111,
1897-1907[Abstract]
|
| 67.
|
Boletta, A.,
Qian, F.,
Onuchic, L. F.,
Bhunia, A. K.,
Phakdeekitcharoen, B.,
Hanaoka, K.,
Guggino, W.,
Monaco, L.,
and Germino, G. G.
(2000)
Mol. Cell
6,
1267-1273[CrossRef][Medline]
[Order article via Infotrieve]
|
| 68.
|
Griffin, M. D.,
Torres, V. E.,
Grande, J. P.,
and Kumar, R.
(1996)
Proc. Assoc. Am. Physcians
3,
185-197
|
| 69.
|
Ward, C. J.,
Turley, H.,
Ong, A. C.,
Comley, M.,
Biddolph, S.,
Chetty, R.,
Ratcliffe, P. J.,
Gattner, K.,
and Harris, P. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1524-1528[Abstract/Free Full Text]
|
| 70.
|
Wienecke, R.,
Konig, A.,
and DeClue, J. E.
(1995)
J. Biol. Chem.
270,
16409-16414[Abstract/Free Full Text]
|
| 71.
|
Xiao, G. H.,
Shoarinejad, F.,
Jin, F.,
Golemis, E. A.,
and Yeung, R. S.
(1997)
J. Biol. Chem.
272,
6097-6100[Abstract/Free Full Text]
|
| 72.
|
Faigle, W.,
Colucci-Guyon, E.,
Louvard, D.,
Amigorena, S.,
and Galli, T.
(2000)
Mol. Biol. Cell
11,
3485-3494[Abstract/Free Full Text]
|
| 73.
|
Palsson, R.,
Sharma, C.,
Kim, K.,
McLaughlin, M.,
Brown, D.,
and Arnaout, M.
(1996)
Mol. Med.
2,
702-711[Medline]
[Order article via Infotrieve]
|
| 74.
|
Pritchard, L.,
Sloane-Stanley, J. A.,
Sharpe, J. A.,
Aspinwall, R.,
Lu, W.,
Buckle, V.,
Strmecki, L.,
Walker, D.,
Ward, C. J.,
Alpers, C. E.,
Zhou, J.,
Wood, W. G.,
and Harris, P. C.
(2000)
Hum. Mol. Genet.
9,
2617-2627[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Streets, B. E. Wagner, P. C. Harris, C. J. Ward, and A. C. M. Ong
Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells
J. Cell Sci.,
May 1, 2009;
122(9):
1410 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Weimbs
Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1
Am J Physiol Renal Physiol,
November 1, 2007;
293(5):
F1423 - F1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Joly, S. Ishibe, C. Nickel, Z. Yu, S. Somlo, and L. G. Cantley
The Polycystin 1-C-terminal Fragment Stimulates ERK-dependent Spreading of Renal Epithelial Cells
J. Biol. Chem.,
September 8, 2006;
281(36):
26329 - 26339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-F. Bui-Xuan, Q. Li, X.-Z. Chen, C. A. Boucher, R. Sandford, J. Zhou, and N. Basora
More than colocalizing with polycystin-1, polycystin-L is in the centrosome
Am J Physiol Renal Physiol,
August 1, 2006;
291(2):
F395 - F406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Qian, W. Wei, G. Germino, and A. Oberhauser
The Nanomechanics of Polycystin-1 Extracellular Region
J. Biol. Chem.,
December 9, 2005;
280(49):
40723 - 40730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Valkova, R. Yunis, S. K. Mak, K. Kang, and D. Kultz
Nek8 Mutation Causes Overexpression of Galectin-1, Sorcin, and Vimentin and Accumulation of the Major Urinary Protein in Renal Cysts of jck Mice
Mol. Cell. Proteomics,
July 1, 2005;
4(7):
1009 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, N. Montalbetti, P. Y. Shen, X.-Q. Dai, C. I. Cheeseman, E. Karpinski, G. Wu, H. F. Cantiello, and X.-Z. Chen
Alpha-actinin associates with polycystin-2 and regulates its channel activity
Hum. Mol. Genet.,
June 15, 2005;
14(12):
1587 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Babich, W.-Z. Zeng, B.-I. Yeh, O. Ibraghimov-Beskrovnaya, Y. Cai, S. Somlo, and C.-L. Huang
The N-terminal Extracellular Domain Is Required for Polycystin-1-dependent Channel Activity
J. Biol. Chem.,
June 11, 2004;
279(24):
25582 - 25589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Cantiello
Regulation of calcium signaling by polycystin-2
Am J Physiol Renal Physiol,
June 1, 2004;
286(6):
F1012 - F1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Grimm, Y. Cai, V. Chauvet, V. Rajendran, R. Zeltner, L. Geng, E. D. Avner, W. Sweeney, S. Somlo, and M. J. Caplan
Polycystin-1 Distribution Is Modulated by Polycystin-2 Expression in Mammalian Cells
J. Biol. Chem.,
September 19, 2003;
278(38):
36786 - 36793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Streets, L. J. Newby, M. J. O'Hare, N. O. Bukanov, O. Ibraghimov-Beskrovnaya, and A. C.M. Ong
Functional Analysis of PKD1 Transgenic Lines Reveals a Direct Role for Polycystin-1 in Mediating Cell-Cell Adhesion
J. Am. Soc. Nephrol.,
July 1, 2003;
14(7):
1804 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Xu, S. Gonzalez-Perrett, M. Essafi, G. A. Timpanaro, N. Montalbetti, M. A. Arnaout, and H. F. Cantiello
Polycystin-1 Activates and Stabilizes the Polycystin-2 Channel
J. Biol. Chem.,
January 10, 2003;
278(3):
1457 - 1462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Igarashi and S. Somlo
Genetics and Pathogenesis of Polycystic Kidney Disease
J. Am. Soc. Nephrol.,
September 1, 2002;
13(9):
2384 - 2398.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|